Oct 29, 2023, 17:56
Vincent Rajkumar: When you grant a for-profit company monopoly rights to a life-saving drug, you must set a ceiling on the price to protect the public— common sense
Quoting Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, on X/Twitter:
“When you grant a for-profit company monopoly rights to a life-saving drug, you must set a ceiling on the price to protect the public— common sense. All developed countries do this. We don’t. No wonder our drug prices are always much higher.
Combine this with laws that allow arbitrary price increases, patent prolongation tactics, and multiple barriers to generic entry, you get this as we see in myeloma.
For details click here.
Source: Vincent Rajkumar/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 26, 2025, 16:32
Feb 26, 2025, 16:31
Feb 26, 2025, 15:47
Feb 26, 2025, 15:38
Feb 26, 2025, 15:34